BACKGROUND: Carboxylesterase (CES) is predominantly responsible for the detoxification of a wide range of drugs and narcotics, and catalyze several reactions in cholesterol and fatty acid metabolism. Studies of the genetic and biochemical properties of primate CES may contribute to an improved understanding of human disease, including atherosclerosis, obesity and drug addiction, for which non-human primates serve as useful animal models. METHODS: We cloned and sequenced baboon CES1 and CES2 and used in vitro and in silico methods to predict protein secondary and tertiary structures, and examined evolutionary relationships for these enzymes with other primate and mouse CES orthologs. RESULTS AND CONCLUSIONS: We found that baboon CES1 and CES2 proteins retained extensive similarity with human CES1 and CES2, shared key structural features reported for human CES1, and showed family specific sequences consistent with their multimeric and monomeric subunit structures respectively.
BACKGROUND: Carboxylesterase (CES) is predominantly responsible for the detoxification of a wide range of drugs and narcotics, and catalyze several reactions in cholesterol and fatty acid metabolism. Studies of the genetic and biochemical properties of primate CES may contribute to an improved understanding of human disease, including atherosclerosis, obesity and drug addiction, for which non-human primates serve as useful animal models. METHODS: We cloned and sequenced baboonCES1 and CES2 and used in vitro and in silico methods to predict protein secondary and tertiary structures, and examined evolutionary relationships for these enzymes with other primate and mouseCES orthologs. RESULTS AND CONCLUSIONS: We found that baboonCES1 and CES2 proteins retained extensive similarity with humanCES1 and CES2, shared key structural features reported for humanCES1, and showed family specific sequences consistent with their multimeric and monomeric subunit structures respectively.
Authors: Drake Morgan; Kathleen A Grant; H Donald Gage; Robert H Mach; Jay R Kaplan; Osric Prioleau; Susan H Nader; Nancy Buchheimer; Richard L Ehrenkaufer; Michael A Nader Journal: Nat Neurosci Date: 2002-02 Impact factor: 24.884
Authors: Tetsuo Satoh; Palmer Taylor; William F Bosron; Sonal P Sanghani; Masakiyo Hosokawa; Bert N La Du Journal: Drug Metab Dispos Date: 2002-05 Impact factor: 3.922
Authors: W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler Journal: Genome Res Date: 2002-06 Impact factor: 9.043
Authors: Roger S Holmes; Matthew W Wright; Stanley J F Laulederkind; Laura A Cox; Masakiyo Hosokawa; Teruko Imai; Shun Ishibashi; Richard Lehner; Masao Miyazaki; Everett J Perkins; Phillip M Potter; Matthew R Redinbo; Jacques Robert; Tetsuo Satoh; Tetsuro Yamashita; Bingfan Yan; Tsuyoshi Yokoi; Rudolf Zechner; Lois J Maltais Journal: Mamm Genome Date: 2010-10-08 Impact factor: 2.957